In vivo role of glucocorticoids in barotrauma vascular repair and fibrosis

M. Asad Karim, Scott Frizzell, Lindsey Inman, Marlene Shinn, Donald D Miller

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To determine the important repair events leading to vascular collagen accumulation following barotrauma, in vivo changes were assessed during dexamethasone (DEX) treatment, as well as physiological healing. Hypercholesterolemic rabbits underwent bilateral iliac artery endothelial denudation, followed by angioplasty. Messenger ribonucleic acid (RNA) (procollagen types I, III and transforming growth factor [TGF]β1), and bio-histometric composition of iliac arteries of animals treated with DEX (2, 7 and 7 days; 1 mg/kg1/day1), were compared to that in controls 2, 7 and 30 days after angioplasty. Type I and III procollagen mRNA transcripts were up-regulated following injury in either group. Similarly, TGFβ1 mRNA levels were also elevated; however, treatment with DEX led to down-regulation at day 30 post-angioplasty. Linear regression and correlation of the densitometric ratios of procollagen α1(I) and TGβ1 mRNA during repair were observed significantly in either group (DEX-treated, r2 = 0.84; non-treated, r2 = 0.79). Biochemically derived total vascular RNA concentration decreased transiently (7 days), with DEX-treatment (P = 0.003). Arterial lumen cross-sectional area was reduced between days 2 and 30 (P = < 0.02), accompained by an increase in fibrillar collagen concentration in both groups of animals post-angioplasty. These results suggest that during barotrauma repair, administration of DEX (~ 1 week), does not affect vascular intimal hyperplasia or fibrosis, and that despite treatment, significant production of type I procollagen mRNA continues, influencing subsequent collagen deposition. The data also confirm a strong correlation between TGFβ1 and type I procollagen mRNA expression, and modestly with type III procollagen during post-angioplasty repair.

Original languageEnglish (US)
Pages (from-to)1111-1122
Number of pages12
JournalJournal of molecular and cellular cardiology
Volume29
Issue number4
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Barotrauma
Dexamethasone
Glucocorticoids
Blood Vessels
Angioplasty
Fibrosis
Messenger RNA
Collagen Type I
Collagen Type III
Iliac Artery
Collagen
RNA
Tunica Intima
Fibrillar Collagens
Procollagen
Transforming Growth Factors
Therapeutics
Hyperplasia
Linear Models
Down-Regulation

Keywords

  • Angioplasty
  • Collagen
  • Extracellular matrix
  • Glucocorticoid
  • TGFβ

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

In vivo role of glucocorticoids in barotrauma vascular repair and fibrosis. / Karim, M. Asad; Frizzell, Scott; Inman, Lindsey; Shinn, Marlene; Miller, Donald D.

In: Journal of molecular and cellular cardiology, Vol. 29, No. 4, 01.01.1997, p. 1111-1122.

Research output: Contribution to journalArticle

Karim, M. Asad ; Frizzell, Scott ; Inman, Lindsey ; Shinn, Marlene ; Miller, Donald D. / In vivo role of glucocorticoids in barotrauma vascular repair and fibrosis. In: Journal of molecular and cellular cardiology. 1997 ; Vol. 29, No. 4. pp. 1111-1122.
@article{a3c3c9d2593f4b31ba7e49e1364a3a51,
title = "In vivo role of glucocorticoids in barotrauma vascular repair and fibrosis",
abstract = "To determine the important repair events leading to vascular collagen accumulation following barotrauma, in vivo changes were assessed during dexamethasone (DEX) treatment, as well as physiological healing. Hypercholesterolemic rabbits underwent bilateral iliac artery endothelial denudation, followed by angioplasty. Messenger ribonucleic acid (RNA) (procollagen types I, III and transforming growth factor [TGF]β1), and bio-histometric composition of iliac arteries of animals treated with DEX (2, 7 and 7 days; 1 mg/kg1/day1), were compared to that in controls 2, 7 and 30 days after angioplasty. Type I and III procollagen mRNA transcripts were up-regulated following injury in either group. Similarly, TGFβ1 mRNA levels were also elevated; however, treatment with DEX led to down-regulation at day 30 post-angioplasty. Linear regression and correlation of the densitometric ratios of procollagen α1(I) and TGβ1 mRNA during repair were observed significantly in either group (DEX-treated, r2 = 0.84; non-treated, r2 = 0.79). Biochemically derived total vascular RNA concentration decreased transiently (7 days), with DEX-treatment (P = 0.003). Arterial lumen cross-sectional area was reduced between days 2 and 30 (P = < 0.02), accompained by an increase in fibrillar collagen concentration in both groups of animals post-angioplasty. These results suggest that during barotrauma repair, administration of DEX (~ 1 week), does not affect vascular intimal hyperplasia or fibrosis, and that despite treatment, significant production of type I procollagen mRNA continues, influencing subsequent collagen deposition. The data also confirm a strong correlation between TGFβ1 and type I procollagen mRNA expression, and modestly with type III procollagen during post-angioplasty repair.",
keywords = "Angioplasty, Collagen, Extracellular matrix, Glucocorticoid, TGFβ",
author = "Karim, {M. Asad} and Scott Frizzell and Lindsey Inman and Marlene Shinn and Miller, {Donald D}",
year = "1997",
month = "1",
day = "1",
doi = "10.1006/jmcc.1996.0330",
language = "English (US)",
volume = "29",
pages = "1111--1122",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - In vivo role of glucocorticoids in barotrauma vascular repair and fibrosis

AU - Karim, M. Asad

AU - Frizzell, Scott

AU - Inman, Lindsey

AU - Shinn, Marlene

AU - Miller, Donald D

PY - 1997/1/1

Y1 - 1997/1/1

N2 - To determine the important repair events leading to vascular collagen accumulation following barotrauma, in vivo changes were assessed during dexamethasone (DEX) treatment, as well as physiological healing. Hypercholesterolemic rabbits underwent bilateral iliac artery endothelial denudation, followed by angioplasty. Messenger ribonucleic acid (RNA) (procollagen types I, III and transforming growth factor [TGF]β1), and bio-histometric composition of iliac arteries of animals treated with DEX (2, 7 and 7 days; 1 mg/kg1/day1), were compared to that in controls 2, 7 and 30 days after angioplasty. Type I and III procollagen mRNA transcripts were up-regulated following injury in either group. Similarly, TGFβ1 mRNA levels were also elevated; however, treatment with DEX led to down-regulation at day 30 post-angioplasty. Linear regression and correlation of the densitometric ratios of procollagen α1(I) and TGβ1 mRNA during repair were observed significantly in either group (DEX-treated, r2 = 0.84; non-treated, r2 = 0.79). Biochemically derived total vascular RNA concentration decreased transiently (7 days), with DEX-treatment (P = 0.003). Arterial lumen cross-sectional area was reduced between days 2 and 30 (P = < 0.02), accompained by an increase in fibrillar collagen concentration in both groups of animals post-angioplasty. These results suggest that during barotrauma repair, administration of DEX (~ 1 week), does not affect vascular intimal hyperplasia or fibrosis, and that despite treatment, significant production of type I procollagen mRNA continues, influencing subsequent collagen deposition. The data also confirm a strong correlation between TGFβ1 and type I procollagen mRNA expression, and modestly with type III procollagen during post-angioplasty repair.

AB - To determine the important repair events leading to vascular collagen accumulation following barotrauma, in vivo changes were assessed during dexamethasone (DEX) treatment, as well as physiological healing. Hypercholesterolemic rabbits underwent bilateral iliac artery endothelial denudation, followed by angioplasty. Messenger ribonucleic acid (RNA) (procollagen types I, III and transforming growth factor [TGF]β1), and bio-histometric composition of iliac arteries of animals treated with DEX (2, 7 and 7 days; 1 mg/kg1/day1), were compared to that in controls 2, 7 and 30 days after angioplasty. Type I and III procollagen mRNA transcripts were up-regulated following injury in either group. Similarly, TGFβ1 mRNA levels were also elevated; however, treatment with DEX led to down-regulation at day 30 post-angioplasty. Linear regression and correlation of the densitometric ratios of procollagen α1(I) and TGβ1 mRNA during repair were observed significantly in either group (DEX-treated, r2 = 0.84; non-treated, r2 = 0.79). Biochemically derived total vascular RNA concentration decreased transiently (7 days), with DEX-treatment (P = 0.003). Arterial lumen cross-sectional area was reduced between days 2 and 30 (P = < 0.02), accompained by an increase in fibrillar collagen concentration in both groups of animals post-angioplasty. These results suggest that during barotrauma repair, administration of DEX (~ 1 week), does not affect vascular intimal hyperplasia or fibrosis, and that despite treatment, significant production of type I procollagen mRNA continues, influencing subsequent collagen deposition. The data also confirm a strong correlation between TGFβ1 and type I procollagen mRNA expression, and modestly with type III procollagen during post-angioplasty repair.

KW - Angioplasty

KW - Collagen

KW - Extracellular matrix

KW - Glucocorticoid

KW - TGFβ

UR - http://www.scopus.com/inward/record.url?scp=0031127232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031127232&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1996.0330

DO - 10.1006/jmcc.1996.0330

M3 - Article

C2 - 9160863

AN - SCOPUS:0031127232

VL - 29

SP - 1111

EP - 1122

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 4

ER -